Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (81)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hirota, N.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirota, N.
Right arrow Articles by Kimura, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 12 2159-2169, Copyright © 1997 by Oxford University Press

ARTICLES

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons

N Hirota, R Kaji, H Bostock, K Shindo, T Kawasaki, K Mizutani, N Oka, N Kohara, T Saida and J Kimura
Department of Neurology, Kyoto University School of Medicine, Japan.

Anti-ganglioside (anti-GM1) antibodies have been implicated in the pathogenesis of Guillain-Barre syndrome, multifocal motor neuropathy and motor neuron diseases. It has been held that they may interfere with saltatory conduction by blocking sodium channels. We tested this hypothesis by analysing action potentials from 140 single nerve fibres in 22 rat ventral roots using external longitudinal current measurement. High-titre anti-GM1 sera from Guillain-Barre syndrome or multifocal motor neuropathy patients, or anti-GM1 rabbit sera were applied to the rat ventral root, where saltatory conduction in single motor fibres was serially observed for 4-12 h (mean 8.2 h). For control experiments, we also tested anti-galactocerebroside (anti-GalC) sera, which causes acute demyelinative conduction block, and tetrodotoxin (TTX), a sodium channel blocker. Conduction block was found in 82% of the fibres treated with anti-GalC sera and 100% treated with TTX, but only in 2% (one out of 44) treated with the patients' sera and 5% (two out of 38) treated with rabbit anti-GM1 sera. All the nodes blocked by anti-GM1 sera revealed intense passive outward membrane current, in the internode just beyond the last active node. This pattern of current flow was similar to that in fibres blocked by demyelination with anti- GalC sera, and quite different from that seen in fibres blocked by reducing sodium currents with TTX. Our findings suggest that anti-GM1 sera neither mediate conduction block nor block sodium channels on their own. We conclude that physiological action of the antibody alone is insufficient to explain clinically observed conduction block in human diseases.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
E. Shavit, O. Beilin, A. D. Korczyn, C. Sylantiev, R. Aronovich, V. E. Drory, D. Gurwitz, I. Horresh, R. Bar-Shavit, E. Peles, et al.
Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block
Brain, April 1, 2008; 131(4): 1113 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Susuki, M. N. Rasband, K. Tohyama, K. Koibuchi, S. Okamoto, K. Funakoshi, K. Hirata, H. Baba, and N. Yuki
Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers
J. Neurosci., April 11, 2007; 27(15): 3956 - 3967.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Capasso, C. M. Caporale, F. Pomilio, P. Gandolfi, A. Lugaresi, and A. Uncini
Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant
Neurology, September 9, 2003; 61(5): 617 - 622.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. J. Willison and N. Yuki
Peripheral neuropathies and anti-glycolipid antibodies
Brain, December 1, 2002; 125(12): 2591 - 2625.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
R. M. Van den Berg-Vos, H. Franssen, J. H. J. Wokke, and L. H. V. d. Berg
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment
Brain, August 1, 2002; 125(8): 1875 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. C. Kiernan, J.-M. Guglielmi, R. Kaji, N. M. F. Murray, and H. Bostock
Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block
Brain, March 1, 2002; 125(3): 664 - 675.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
R. Kaji and J. Kimura
Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies
Brain, May 1, 1999; 122(5): 797 - 798.
[Full Text] [PDF]

Home page
 BrainHome page
K. Paparounas, G. M. O'Hanlon, C. P. O'Leary, E. G. Rowan, and H. J. Willison
Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro
Brain, May 1, 1999; 122(5): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. A. Sheikh, T. J. Deerinck, M. H. Ellisman, and J. W. Griffin
The distribution of ganglioside-like moieties in peripheral nerves
Brain, March 1, 1999; 122(3): 449 - 460.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. C. Gominak and D. P. Cros
Case 13-1998- A 23-Year-Old Man with Progressive Weakness and Paresthesias
N. Engl. J. Med., April 23, 1998; 338(17): 1212 - 1219.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.